Equashield is a leading global provider of closed system transfer devices (CSTDs) designed to protect healthcare professionals from exposure to hazardous drugs.
With a relentless focus on quality, safety, and ease of use, Equashield’s product offerings are based on proprietary technologies spanning both manual CSTDs and novel automated compounding solutions – including a next-generation automated compounding system utilising artificial intelligence to deliver superior performance.
- Since its founding in 2009, Equashield has recorded robust growth fuelled by continued product innovation, high customer satisfaction, and the pioneering of new technological solutions for handling hazardous drugs.
- Products are sold across five continents Equashield is a leading CSTD provider in the largest global market, the US.
Vision & Outlook
- Opportunity to leverage its technological edge to further accelerate growth.
- Pipeline of innovative compounding technologies, including a novel automated drug compounding system.
- Vast potential of compounding automation to improve safety and efficiency in the handling of hazardous drugs.
EUR 100 million